ISP-002

N/A

Report date: 2022/05/10 11:52:44

Base Information

Drug NameISP-002
Drug Alias NameISP002
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionCell replacementsIduronate-2-sulfatase replacementsGene transference
TargetsIduronate-2-sulfatase
Therapy Area/IndicationsMucopolysaccharidosis II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmusoft Corp
China Registration ClassN/A

Develop Information

Active CompaniesImmusoft Corp
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A